Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Haap

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Diabetes Care|October 27, 2004
Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjectsClaus Thamer, Jürgen Machann, Michael Haap, et al.
Obesity (Silver Spring, Md.)|February 15, 2007
High visceral fat mass and high liver fat are associated with resistance to lifestyle interventionClaus Thamer, Juergen Machann, Norbert Stefan, et al.
Thoracic Cancer|May 7, 2020
Life-threatening pneumonitis after first-line treatment with osimertinib for primary T790M mutated non-small cell lung cancerMaik Häntschel, Johannes Niebling, Almut Häring, et al.
Journal of Visualized Experiments : Jove|December 25, 2018
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic LeukemiaAlexander R Fuchs, Melanie Märklin, Jonas S Heitmann, et al.
Diabetes Care|July 2, 2003
Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetesClaus Thamer, Michael Stumvoll, Andreas Niess, et al.
Metabolism: Clinical and Experimental|June 12, 2003
Increased insulin clearance in peroxisome proliferator-activated receptor gamma2 Pro12AlaOtto Tschritter, Andreas Fritsche, Norbert Stefan, et al.
International Journal of Cardiology|July 9, 2011
Platelet expression of stromal-cell-derived factor-1 (SDF-1): an indicator for ACS?Thomas Wurster, Konstantinos Stellos, Michael Haap, et al.
Deutsche Medizinische Wochenschrift (1946)|September 20, 2016
[An unexpected cause of dyspnea and degradation of performance]Peter Seizer, Michaela Rockenstiehl, Suzanne Fateh-Moghadam, et al.
Frontiers in Neurology|January 21, 2025
Retrospective analysis of amantadine response and predictive factors in intensive care unit patients with non-traumatic disorders of consciousnessCorinna Blum, Constanze Single, Kornelia Laichinger, et al.
Journal of Leukocyte Biology|December 18, 2018
Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemiaDavid J Müller, Stefan Wirths, Alexander R Fuchs, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Diabetes Care|October 27, 2004
Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjectsClaus Thamer, Jürgen Machann, Michael Haap, et al.
Obesity (Silver Spring, Md.)|February 15, 2007
High visceral fat mass and high liver fat are associated with resistance to lifestyle interventionClaus Thamer, Juergen Machann, Norbert Stefan, et al.
Thoracic Cancer|May 7, 2020
Life-threatening pneumonitis after first-line treatment with osimertinib for primary T790M mutated non-small cell lung cancerMaik Häntschel, Johannes Niebling, Almut Häring, et al.
Journal of Visualized Experiments : Jove|December 25, 2018
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic LeukemiaAlexander R Fuchs, Melanie Märklin, Jonas S Heitmann, et al.
Diabetes Care|July 2, 2003
Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetesClaus Thamer, Michael Stumvoll, Andreas Niess, et al.
Metabolism: Clinical and Experimental|June 12, 2003
Increased insulin clearance in peroxisome proliferator-activated receptor gamma2 Pro12AlaOtto Tschritter, Andreas Fritsche, Norbert Stefan, et al.
International Journal of Cardiology|July 9, 2011
Platelet expression of stromal-cell-derived factor-1 (SDF-1): an indicator for ACS?Thomas Wurster, Konstantinos Stellos, Michael Haap, et al.
Deutsche Medizinische Wochenschrift (1946)|September 20, 2016
[An unexpected cause of dyspnea and degradation of performance]Peter Seizer, Michaela Rockenstiehl, Suzanne Fateh-Moghadam, et al.
Frontiers in Neurology|January 21, 2025
Retrospective analysis of amantadine response and predictive factors in intensive care unit patients with non-traumatic disorders of consciousnessCorinna Blum, Constanze Single, Kornelia Laichinger, et al.
Journal of Leukocyte Biology|December 18, 2018
Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemiaDavid J Müller, Stefan Wirths, Alexander R Fuchs, et al.
Pageof 8